| Website | springbankpharm.com |
| Category | BioTech |
| Phone | 508-473-5993 |
| info@springbankph... | |
| Employees |
| TOTAL | $3.9M |
| FUNDING TOTAL | $3.9M |
| Grant, 5/11 National Institutes of Health | $3.9M |
Spring Bank Pharmaceuticals is an IND-stage drug discovery company. Based on their proprietary platform technology, they are developing a pipeline of products representing a new class of pharmaceuticals they call small molecule nucleic acid hybrids “SMNH†with a wide range of applications and multi-billion dollar market potential.
